FOLFOXIRI and Bevacizumab clinical trials

Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.

This study looks at a new way to treat bowel cancer that has spread only to the liver and can't be removed with surgery. We're testing a combination of medicines (FOLFOXIRI and bevacizumab) to see if it can shrink the tumours enough so they can be operated on, aiming for a cure.